Abinopharm
CompanyUnited States
Abinopharm develops one asset, in phase 1 (Nicotinamide Mononucleotide in enhance immune function). Mostly supplement acting on Mitochondrial biogenesis (PGC-1α), sirtuin signalling and NAD+ metabolism; based in the United States.
- 1
- Asset
- Furthest stage
- Phase 1
- 1
- Trial
- 5
- Signals
Pipeline
1NAD+ precursor supplement that boosts cellular NAD+ levels and supports mitochondrial metabolism
Phase 1, Supplement, Mitochondrial biogenesis (PGC-1α), Sirtuin signalling, enhance immune function, aging (Human trials)
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms4
- Trials2
- Signals20
- Similar companies6